Zenflow, Inc. | 2,956 followers on LinkedIn. Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction. To meet this clinical need, Zenflow has developed the Spring System.